Unknown

Dataset Information

Diagnostic utility of procalcitonin as a biomarker for late-onset neonatal sepsis.


ABSTRACT:

Background

To explore the diagnostic utility of procalcitonin (PCT) as a biomarker for late-onset neonatal sepsis (LONS).

Methods

The clinical and laboratory data of 131 neonatal patients in the neonatal intensive cares unit (NICU) of our center (Department of Neonatology, Renmin Hospital of Wuhan University) from June 1, 2015, to May 31, 2018, were retrospectively analyzed. These patients were divided into 3 groups based on their disease conditions: the bacterial sepsis (BS) group (n=47), the fungal sepsis (FS) group (n=39), and the normal control group (n=45, without sepsis). Blood cultures, routine blood tests, and testing for PCT and C-reactive protein (CRP) were performed in all 3 groups. Both PCT and CRP were measured by using enzyme-linked immunosorbent assay (ELISA).

SUBMITTER: Liu C 

PROVIDER: S-EPMC7347773 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature